{"schema_version":"secwatch.filing_event.v1","accession":"0001193805-26-000181","form_type":"8-K","ticker":"IMUX","cik":"0001280776","company_name":"IMMUNIC, INC.","filed_at":"2026-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:34.695667+00:00","generated_at":"2026-05-15T23:26:56.881070+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Immunic closes $200M private placement; CEO Vitt to transition; Phase 3 MS data by end-2026","bullets":["Closed oversubscribed private placement of up to $400M; $200M gross proceeds received Feb 17, 2026.","Net proceeds ~$187M expected to fund operations into late 2027, including Phase 3 ENSURE trials and NDA submission mid-2027.","CEO Daniel Vitt to transition to senior scientific role; search for new CEO with commercial MS expertise underway.","Simona Skerjanec appointed Interim Chairperson; Thor Nagel (BVF Partners) named to Board.","Net loss for FY2025 was $97.2M ($0.62/share); cash $15.5M at Dec 31, 2025, plus placement proceeds."],"urls":{"canonical":"https://secwatch.observer/filing/0001193805-26-000181","json":"https://secwatch.observer/filing/0001193805-26-000181.json","markdown":"https://secwatch.observer/filing/0001193805-26-000181.md","text":"https://secwatch.observer/filing/0001193805-26-000181.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000181/0001193805-26-000181-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1280776/000119380526000181/e665186_8k-immunic.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T23:26:56.881070+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}